DM-XTech UK Ltd.
Immediate tLCAF/DoC availability · UK/EU CPOA entry · Philippine WCS scale platform
DM-XTech UK Ltd. is positioning the Series A as an institutional formation round that converts ASTM D1655-compliant tLCAF and DoC Jet A-1 availability into first-adopter airline CPOAs, toll-manufacturing execution, Philippine host-country alignment, and a sponsorable public-market aviation-fuels platform.
This memorandum is a confidential discussion draft prepared for selected sophisticated investors, family offices, strategic investors, SPAC sponsors, investment banks, directors, executives and professional advisers. It is not a prospectus, admission document, approved financial promotion, public offer, investment advice or solicitation in any jurisdiction.
All commercial, technical, regulatory, pricing and financial statements remain subject to due diligence, counsel review, definitive documentation, board approval and applicable securities-law compliance. The fuel-property and EU non-CO₂ MRV discussion in this memorandum is framed as verifier-usable data relevance and customer diligence support. It is not a representation that any airline will receive a specific regulatory credit, allowance, offset, EU ETS benefit, CORSIA benefit, NEATS result or verified emissions outcome from using any DM-XTech product. Financial scenarios presented in this memorandum are illustrative only and do not constitute profit forecasts, projections or guaranteed outcomes.
tLCAF — Tailored Low-Carbon Aviation Fuel: ASTM D1655-compliant, low-aromatic, ultralow-sulphur Jet A-1 product differentiated by controlled fuel-property composition. · DoC Jet A-1 — Duty-of-Care Jet A-1: ultralow-sulphur, low-naphthalene aviation fuel for occupational-exposure-sensitive users. · zLCAF — Zero-aromatic LCAF candidate subject to independent OEM/TERC validation. · CPOA — Contingent Product Offtake Agreement: conditional fuel-supply contract allowing airline evaluation without long-term volume commitment. · TMA — Toll Manufacturing Arrangement: contract production at a qualified third-party refinery. · WCS — Western Canadian Select: heavy sour crude grade proposed as feedstock for the Philippine refinery. · TERC — Technical Evaluation and Review Consortium: the independent technical advisory body engaged to support tLCAF's fuel-property narrative and product specification framework. · EU MRV — EU Monitoring, Reporting and Verification framework for aviation non-CO₂ effects under Regulation (EU) 2024/2493. · NEATS — Non-CO₂ Effects Assessment Tool for aviation, used by the European Aviation Safety Agency within the MRV framework. · eSAF — electro-SAF or Power-to-Liquid: synthetic aviation fuel produced from low-carbon hydrogen and captured CO₂.
DM-XTech UK is positioned as the exclusive UK/EU commercial route for immediately available tLCAF and DoC Jet A-1, both ASTM D1655-compliant Jet A-1 products. The Series A funds the company architecture needed to convert that availability into first-adopter airline CPOAs, toll-manufacturing capacity, governance credibility and a SPAC-scale refinery platform anchored in the Philippines as a strategic host country.
First-adopter airlines in the United Kingdom and the European Union can evaluate tLCAF and DoC Jet A-1 under Contingent Product Offtake Agreements designed around batch-specific specifications, QA release, traceability, import logistics and EU non-CO₂ MRV-relevant fuel-property documentation.
The EU non-CO₂ MRV regime creates a new data-driven procurement dialogue around flight fuel properties, including aromatics, sulphur and naphthalene. DM-XTech is not selling a regulatory credit; it is selling compliant fuel with differentiated property data for airline and verifier workflows.
The long-term platform is not merely a refinery site decision. A Pacific-facing Philippine WCS refinery gives DM-XTech a chokepoint-resilient crude route and gives the Philippines a private-sector pathway toward deeper refining capability, advanced-fuels exports and greater fuel independence.
DM-XTech UK Ltd. is incorporated in England and Wales and acts as the UK/EU commercial and capital-markets vehicle for the DM-XTech group. The company was established to commercialise a proprietary aviation fuel composition platform — tLCAF, DoC Jet A-1 and zLCAF — that is differentiated by controlled fuel properties relevant to EU non-CO₂ MRV, duty-of-care procurement and future zero-aromatics aviation requirements.
DM-XTech's product platform originated from the founder's research into the commercial gap between CORSIA lifecycle-GHG-focused aviation fuel definitions and the emerging EU non-CO₂ MRV data architecture. The insight was that airlines would face a new class of fuel-property reporting obligations — around aromatics, sulphur and naphthalene — for which conventionally-formulated Jet A-1 provides only default-level data. DM-XTech's tLCAF and DoC Jet A-1 were developed to address that gap with ASTM D1655-compliant, compositionally-controlled fuels supported by batch-specific, traceable documentation.
The founder originated the DM-XTech fuel-composition platform, established the tLCAF and DoC Jet A-1 technical framework and holds or controls the proprietary formulations through DM-XTechPhil. The founder's role in a post-Series A structure transitions to technical strategy and product development, with independent governance complementing the executive team.
The Series A funds the appointment of a Chairman with a public-company energy-sector background capable of supporting investor confidence, SPAC sponsor engagement, high-net-worth investor introductions and board-level governance. The Chairman mandate will be disclosed to lead investors prior to commitment.
A full-time or interim CFO with deSPAC-capable finance experience will be appointed as a priority Series A action. The CFO mandate includes audit readiness, disclosure controls, financial model integrity, SPAC diligence, PIPE investor process, project-finance interfaces and investor reporting.
Senior counsel with capital markets, IP/licensing, toll manufacturing, UK/Philippines and securities-law experience will be retained as a Series A priority. The General Counsel role will also build related-party governance around the DM-XTech UK / DM-XTechPhil interface.
An operations leader will coordinate CPOA conversion, TMA implementation, quality systems, logistics, customer delivery and refinery-platform workstreams.
TERC — the Technical Evaluation and Review Consortium — is the independent technical advisory body engaged to support tLCAF's fuel-property narrative, product specification framework and ASTM D1655 compliance evidence. A technical claims review committee will be constituted as a Series A governance priority.
DM-XTechPhil is the Philippine-incorporated entity that holds and supplies the proprietary formulations, fuel-chemistry know-how and technical process support for tLCAF and DoC Jet A-1 production. DM-XTechPhil is a related entity to DM-XTech UK Ltd. under common founder control. A formal commercial and IP licensing agreement between DM-XTech UK and DM-XTechPhil — governing formulation rights, exclusivity, territory, improvements and trade-secret controls — is a Series A legal priority and will be documented before investor close. The UK entity's commercial rights must be contractually secured against the Philippine-held IP before the Series A can be regarded as fully de-risked on the technology supply chain.
Commission Implementing Regulation (EU) 2024/2493 and the associated EU non-CO₂ MRV guidance create a reporting architecture in which aircraft operators monitor and report non-CO₂ aviation effects and may use fuel-property data within approved monitoring workflows. For DM-XTech, the commercial opportunity is not to promise regulatory outcomes, but to supply ASTM D1655-compliant fuel with lower aromatics, ultralow sulphur and low naphthalene properties that are relevant to airline monitoring, reporting and verifier review.
The EU guidance identifies flight fuel properties as data inputs under the non-CO₂ MRV framework. Relevant properties include aromatic content, sulphur, naphthalene content, hydrogen-to-carbon ratio and net calorific value.
Where fuel-property data is not provided as primary data, NEATS may use default Jet A-1 limit values. The ability to supply batch-specific, traceable fuel-property documentation can therefore become commercially relevant for operators seeking more precise internal and verifier-facing datasets.
tLCAF and DoC Jet A-1 are positioned as MRV-relevant property-data fuels, not as automatic EU ETS, CORSIA or NEATS outcome products.
| EU MRV data issue | Commercial implication for airlines | DM-XTech response |
|---|---|---|
| Aromatics | Aromatics are associated with soot/nvPM formation and contrail-relevant mechanisms; they are also a monitored fuel-property category under the EU non-CO₂ MRV data framework. | tLCAF's current technical narrative includes an 8.5 vol% aromatics profile, materially below the 25 vol% Jet A-1 default value referenced in EU guidance. |
| Sulphur | Sulphur species contribute to aviation non-CO₂ aerosol pathways and are a monitored fuel-property category in the EU framework. | tLCAF and DoC Jet A-1 are positioned as ultralow-sulphur aviation fuels, with commercial batches documented through QA and traceability packs. |
| Naphthalene | Naphthalene is specifically tracked as a fuel-property category and is relevant to duty-of-care and exposure-sensitive aviation use cases. | DoC Jet A-1 targets <85 ppm naphthalene versus a Jet A-1 default limit of approximately 3 vol% (equivalent to ~30,000 ppm by volume) referenced in EU guidance — a reduction of over 99%. |
| Primary data | Airlines benefit from fuel suppliers capable of producing credible primary fuel-property evidence rather than relying solely on secondary or default assumptions. | CPOA shipments are supported by batch QA, certificate of analysis, chain-of-custody, container/drum traceability and fuel-property data packs. |
The airline-facing message is: DM-XTech supplies ASTM D1655-compliant aviation fuel with differentiated, traceable fuel-property data. The airline, its verifier and its competent authority determine how those data are used within the applicable MRV process.
tLCAF and DoC Jet A-1 are positioned as immediately available, ASTM D1655-compliant Jet A-1 products for UK and EU first adopters. zLCAF remains an advanced zero-aromatics candidate subject to independent OEM and TERC validation before commercial deployment. SAF and eSAF remain the long-horizon scalability pathways within the WCS Refinery platform.
| Product | Technical profile | Near-term commercial role | Disclosure discipline |
|---|---|---|---|
| tLCAF | ASTM D1655-compliant, low-aromatic, ultralow-sulphur Jet A-1; TERC-supported technical narrative includes approximately 8.5 vol% aromatics. | First-adopter airline CPOAs in the UK/EU; MRV-relevant fuel-property data; TMA-enabled production bridge; eventual WCS refinery scale-up. | Presented as a compliant Jet A-1 fuel with differentiated properties, not as a guaranteed EU ETS, CORSIA or contrail-reduction credit. |
| DoC Jet A-1 | ASTM D1655-compliant, ultralow-sulphur, low-naphthalene duty-of-care Jet A-1 targeting <85 ppm naphthalene. | First-adopter airline, defence aviation, helicopter, rotary-wing and occupational-exposure-sensitive aviation discussions. | Presented as a duty-of-care and fuel-property product, not as a medical or toxicological outcome claim. |
| zLCAF | Zero-aromatics, ultralow-sulphur advanced aviation fuel candidate. Currently in development; independent OEM and TERC validation required before commercial deployment. | OEM, TERC, Airbus and future validation pathway; potential high-upside product for a zero-aromatics aviation future. Not available for immediate commercial CPOA deployment. | Presented as validation-dependent and clearly separate from immediate tLCAF/DoC commercial availability. No customer commitments will be accepted for zLCAF until validation milestones are achieved. |
| SAF / bio-SAF | Long-horizon sustainable aviation fuel pathways, including potential biomass-to-biocrude and refinery-upgrading routes. | Future product island in the WCS Refinery & Advanced Fuels Platform. | Eligibility depends on feedstock, pathway, lifecycle-carbon accounting and certification. |
| eSAF / PtL | Synthetic aviation fuel produced from captured CO₂ and low-carbon hydrogen. | Premium long-term product for mandates and strategic aviation customers. | High cost and infrastructure intensity make this a long-horizon scale product, not the immediate revenue base. |
CORSIA LCAF is defined around lifecycle GHG reduction, including a minimum 10% lifecycle-emissions reduction against the CORSIA aviation-fuel baseline. A CORSIA-eligible LCAF can still be an ASTM D1655 fuel that does not specifically optimise aromatics, sulphur or naphthalene unless those properties are deliberately controlled.
tLCAF is positioned to address both CO₂-adjacent lifecycle narratives and non-CO₂ property relevance by combining ASTM D1655 compliance with a low-aromatic and ultralow-sulphur profile.
DoC Jet A-1 creates a second immediate product route by focusing on low naphthalene and occupational-exposure-sensitive users, including air forces, rotary-wing operations and maintenance-intensive aviation environments.
DM-XTech UK intends to offer tLCAF and DoC Jet A-1 to first-adopter airlines in the UK and EU through Contingent Product Offtake Agreements. The CPOA structure gives airlines a controlled route to evaluate product specifications, MRV-relevant data packs, delivery logistics and price terms without requiring immediate long-term refinery-scale commitments.
| CPOA element | Indicative position | Investor relevance |
|---|---|---|
| Counterparty | First-adopter airline, air force, defence aviation user, fuel distributor or airport/fuel-services partner. | Creates market evidence before refinery-scale capex. |
| Principal commercial party | DM-XTech UK Ltd. for UK and EU market customers. | Supports valuation of the UK issuer and its exclusive market role. |
| Supply dependency | Product supply depends on qualified TMA production or initial limited commercial availability under DM-XTechPhil formulation and technical support. | Creates a realistic bridge from immediate availability to contracted production. |
| Minimum commercial lot | Current working logistics package: 1,600,000 litres, 200-litre drums, 8,000 drums, 100 × 20-foot containers. | Large enough for serious trial use, inventory control and first-adopter diligence. |
| Market engagement status | DM-XTech is in preparatory discussions with potential first-adopter airline and defence aviation counterparties in the UK and EU. No binding CPOAs have been executed. Specific counterparties will be disclosed to lead investors under NDA during diligence. | Customer pipeline evidence is a Series A priority and will be updated as discussions progress. |
| Customer value | ASTM D1655 compliance, differentiated properties, low-friction procurement economics and MRV-relevant documentation. | Customer traction can support Series A, SPAC and PIPE diligence. |
The near-term production bridge is a Toll Manufacturing Arrangement with a qualified oil-refining company in the Philippines, Singapore or India. DM-XTech UK will act as principal under the TMA contract. DM-XTechPhil will provide the proprietary formulations for tLCAF and DoC Jet A-1 and, where required, the refinery reconfiguration or process-adjustment plan needed to meet the required product specifications.
DM-XTech UK is the UK/EU commercial counterparty to first-adopter customers and the intended principal under the TMA contract with the selected refinery. This places the UK issuer at the centre of commercial margin, customer contracting and supply-chain accountability.
DM-XTechPhil — the Philippine-incorporated entity under founder control — supplies the formulations, fuel-chemistry know-how, technical supervision and, if required, the refinery reconfiguration plan or process package. The IP licensing arrangement between DM-XTech UK and DM-XTechPhil will be formally documented as a Series A legal priority (see Section 14: Corporate Structure).
A refinery in the Philippines, Singapore or India provides processing capacity, batch production, quality controls, tankage, blending and release systems under a confidential toll-manufacturing model. Specific refinery counterparties are not disclosed at this stage; they will be identified to investors during diligence under NDA.
| TMA workstream | Operating model | Diligence focus |
|---|---|---|
| Refinery selection | DM-XTech UK selects an oil refinery with suitable hydrotreating, blending, tankage, QA and export capabilities. | Capacity, confidentiality, product isolation, process compatibility, QC systems, export approvals and commercial terms. |
| Formula and process package | DM-XTechPhil supplies proprietary formulations and, where needed, a reconfiguration or process-adjustment plan. | Trade-secret controls, technical transfer protocol, documentation limits, ownership of improvements and liability allocation. |
| Batch production | The refinery processes designated feedstocks/intermediates and releases product against agreed tLCAF or DoC Jet A-1 specifications. | Specification conformance, ASTM D1655 testing, certificate of analysis, retention samples and independent lab verification. |
| Logistics | Drumming, containerisation, insurance, export/import paperwork, port handling and delivery to customer-designated locations. | Cost, chain of custody, contamination prevention, customs classification, dangerous-goods handling and title/risk transfer. |
| Scale transition | TMA supports first-adopter demand until the WCS Refinery can produce at platform scale. | Customer continuity, margin evolution and evidence for project finance. |
The IM discloses the structure — DM-XTech UK as TMA principal, DM-XTechPhil as formulation and technical source, and refinery counterparties in the Philippines, Singapore or India — without naming specific target refineries unless a term sheet, consent or formal mandate exists. This gives investors a credible supply-chain explanation while preserving negotiating leverage and confidentiality.
The comparative-pricing strategy is designed to make first adoption economically defensible for airlines while preserving the long-term scale thesis. Management's current pricing framework treats tLCAF and DoC Jet A-1 as differentiated ASTM D1655 products that should enter the market at a modest premium to conventional Jet A-1 — materially below the SAF price band, and broadly comparable to CORSIA LCAF economics. Once the WCS Refinery is fully operational, the target is parity pricing with conventional Jet A-1.
| Fuel category | Indicative market / pricing position | Commercial implication |
|---|---|---|
| Conventional Jet A-1 | Management comparative-pricing note indicates approximately US$730–745 per metric tonne in Northwest Europe. | Baseline customer reference price. |
| CORSIA LCAF | Approximately US$780–820 per metric tonne — a US$40–80 per metric tonne premium over conventional Jet A-1. | LCAF economics are manageable compared with SAF, but still represent a premium product category. |
| tLCAF CPOA launch pricing | Targeted at a modest premium over conventional Jet A-1, broadly in line with CORSIA LCAF premium levels. Subject to TMA economics, logistics, customs, insurance and customer-specific terms. | Creates a materially lower adoption hurdle than SAF while highlighting differentiated fuel properties for MRV-relevant workflows. |
| DoC Jet A-1 CPOA launch pricing | Targeted at approximately 20% premium over tLCAF launch pricing, reflecting the additional product specification controls and occupational-exposure narrative. Subject to final TMA and logistics economics. | Premium justified by duty-of-care positioning for defence aviation, rotary-wing and maintenance-intensive users. |
| WCS Refinery steady-state target | Parity pricing with conventional Jet A-1 once the dedicated refinery platform is fully operational and efficiently scaled. | Transforms tLCAF and DoC Jet A-1 from premium early-adopter fuels into scalable commercial aviation-fuel products. |
| SAF / eSAF | SAF remains materially more expensive than conventional Jet A-1; eSAF is higher-cost and infrastructure-intensive. | DM-XTech's portfolio is not dependent solely on scarce SAF feedstocks or high-cost eSAF pathways. |
First adopters need a reason to move before regulations attach direct financial benefits to non-CO₂ fuel properties. A low initial premium reduces procurement friction and lets airlines test the data, logistics and verifier narrative.
The WCS Refinery target is to make lower-aromatic, ultralow-sulphur aviation fuel economically mainstream — not permanently dependent on boutique premiums.
SAF and eSAF remain important, but their current supply and cost constraints create an opening for ASTM-compliant LCAF-family fuels that can be commercially introduced sooner and at lower procurement risk.
The Series A is a priced preferred-equity financing, not a SAFE, bridge note or ordinary venture round. It is designed to fund institutional management, customer conversion, TMA supply, UK–Philippines rights formalisation, WCS platform diligence and public-market readiness.
| Term | Indicative position | Investment rationale |
|---|---|---|
| Issuer | DM-XTech UK Ltd., incorporated in England and Wales. | UK issuer serves as the commercial, capital-markets and deSPAC-readiness vehicle. |
| Instrument | Series A Preferred Equity. | Institutional investors receive defined class rights and governance protections. |
| Target raise | US$100 million. | Funds the credibility bridge from immediate CPOA availability to SPAC-ready infrastructure platform. |
| Use of proceeds | Management, governance, CPOA conversion, TMA execution, WCS pre-FEED, host-country engagement, legal/IP structuring and data room. | Each workstream creates objective evidence for sponsor, PIPE and project-finance diligence. |
| Preferred rights | Expected to include liquidation preference (1× non-participating as a minimum), conversion rights, broad-based weighted-average anti-dilution, information rights, board representation, pre-emption, reserved matters and governance covenants. | Clear rights address institutional investor concerns and avoid the ambiguity of earlier SAFE-style instruments. |
| Valuation | To be negotiated with lead investors and supported by independent diligence. Any scenario valuation in this document remains illustrative until documented in a definitive term sheet. | Valuation should reflect milestone probability, not an unbuilt refinery as though already constructed. |
| Expected return pathway | Series A investors are expected to realise value primarily through the deSPAC exit, at which point their preferred shares convert into public-company stock at agreed terms. Illustrative scenarios are presented in Section 15. | The deSPAC provides a defined liquidity event pathway for preferred shareholders, subject to SPAC market conditions and sponsor engagement. |
| Dividend | Cumulative preferred dividend at a rate to be agreed with lead investors; accrued and payable on a deSPAC or liquidity event if not earlier converted. | Provides downside yield protection and aligns incentives around timely milestone execution. |
The US$100M Series A is allocated across immediate commercialisation, institutional formation and refinery-platform financeability. The budget is intended to produce customer evidence, operating capacity, legal clarity, Philippine strategic-alignment documentation and capital-markets credibility.
| Use of proceeds | Indicative allocation | Purpose |
|---|---|---|
| Board, C-suite and public-company readiness | US$18M | Independent Chairman, SPAC-ready CFO, COO, General Counsel, audit readiness, controls, reporting, executive search and compensation. |
| CPOA commercialisation and MRV evidence packs | US$20M | Airline and defence first-adopter campaigns, fuel-property documentation, certificates of analysis, traceability packs, customer diligence, verifier-facing data support and TERC/OEM engagement. |
| TMA negotiation and first-shipment bridge | US$18M | Refinery due diligence in the Philippines, Singapore and India; TMA contracting; technical transfer controls; batch production; drumming/containerisation; insurance; logistics; first-shipment readiness. |
| WCS Refinery & Advanced Fuels Platform | US$20M | Pre-FEED, Pacific-facing site screening, WCS supply chain, refinery configuration, product slate, SAF/eSAF islands, power/hydrogen/carbon architecture and financial model. |
| Philippine host-country alignment and Pacific corridor strategy | US$14M | Philippine government engagement, national fuel-security case, economic-impact study, incentives and permits map, Canada–Philippines WCS route brief, port/logistics strategy and strategic communications. |
| IP structuring, UK–Philippines rights formalisation and legal | US$6M | IP licensing agreement between DM-XTech UK and DM-XTechPhil; trade-secret framework; patent assessment; securities-law compliance; data-room preparation. |
| Working capital and contingency | US$4M | Operational headroom, FX management, unforeseen costs during institutional formation period. |
DM-XTech's credibility increases materially when the founder's technical leadership is complemented by independent governance, public-company finance capability, operating leadership and legal architecture. The Series A funds that transition.
A public-company energy-sector Chairman profile strengthens governance, investor confidence and SPAC sponsor credibility. The Chairman candidate may also support lead-investor formation and high-net-worth investor introductions.
The CFO mandate includes audit readiness, disclosure controls, financial model integrity, SPAC diligence, PIPE investor process, project-finance interfaces and investor reporting.
An operations leader coordinates CPOA conversion, TMA implementation, quality systems, logistics, customer delivery and refinery-platform workstreams.
| Institutional role | Current requirement | Series A action |
|---|---|---|
| Chairman | Independent public-company energy profile. | Formal appointment or Chair-designate agreement; governance mandate; investor-facing role. |
| CFO | Public-company and deSPAC-capable finance leader. | Hire full-time or interim SPAC-ready CFO through executive platform or direct search. |
| General Counsel | Capital markets, IP/licensing, TMA, UK/Philippines and securities-law discipline. | Retain counsel and build related-party governance around DM-XTech UK and DM-XTechPhil. |
| Technical governance | Claims discipline around ASTM D1655, non-CO₂ MRV, CORSIA, SAF/eSAF and occupational exposure. | Create technical claims review committee and evidence register; formalise TERC engagement scope. |
| Audit and controls | Financial reporting, controls, budget discipline and data-room integrity. | Implement controls architecture suitable for sponsor and PIPE diligence. |
| Related-party governance | Arm's-length relationship between DM-XTech UK and DM-XTechPhil; founder conflict-of-interest management. | Board committee oversight; independent legal review of all DM-XTech UK / DM-XTechPhil transactions; disclosure framework. |
The Philippine WCS Refinery & Advanced Fuels Platform is the principal reason the opportunity can become SPAC-scale. Immediate tLCAF and DoC Jet A-1 CPOAs create market evidence; TMA production supplies early volumes; the WCS Refinery provides the route to commercial parity, product breadth and infrastructure-scale value. WCS refers to Western Canadian Select — a heavy sour crude grade proposed as the primary feedstock for the refinery, sourced via a Pacific corridor route from Canada to the Philippines.
The refinery is conceived as a Pacific-facing Philippine platform using Western Canadian Select to reduce exposure to Middle East, Malacca and South China Sea routing risks. This is more than logistics; it is the basis for a strategic crude-to-products corridor.
The dedicated refinery is intended to produce tLCAF, DoC Jet A-1 and other advanced fuels at scale, with a target of parity pricing against conventional Jet A-1 once the platform is fully operational. zLCAF will be included in the refinery product slate only upon completion of independent OEM and TERC validation.
A Philippine WCS platform can contribute to domestic refining depth, import substitution, hard-currency advanced-fuels exports, industrial employment and fuel-security resilience. The host-country thesis is part of the platform's bankability, not an afterthought.
A greenfield or brownfield integrated refinery platform of the scale required to produce tLCAF, DoC Jet A-1 and advanced fuels for Pacific aviation markets would require multi-billion-dollar project financing — indicatively in the range of US$3–6 billion for a meaningful initial capacity, depending on site, configuration, product slate, WCS import infrastructure, hydrogen and carbon architecture. This places the refinery firmly in the category of infrastructure-scale, project-finance-backed assets. The Series A (US$100M) is not intended to fund refinery construction; it funds the evidence base — pre-FEED, financial model, host-country alignment, customer pipeline — that makes that project finance accessible to a SPAC-backed entity. The refinery capex range is indicative only and subject to pre-FEED and site assessment.
Most refinery proposals are evaluated as sites, permits and economics. DM-XTech's Philippine WCS platform should be evaluated as a strategic alignment: the company needs a host country with import-substitution incentives, Pacific-coast infrastructure and fuel-security motivation. The Philippines provides all three and offers DM-XTech a sovereign-alignment narrative that is bankable in multilateral and ECA-backed financing discussions.
The WCS Refinery & Advanced Fuels Platform is designed to align DM-XTech's long-term commercial interest with the Philippines' long-term national interest. DM-XTech requires a strategically relevant host country for a refinery-scale advanced-fuels platform; the Philippines requires a credible private-sector pathway toward greater fuel independence, domestic refining depth, foreign-exchange resilience and export-oriented advanced-fuels industrialisation.
The Philippine economy remains exposed to imported finished fuels, maritime disruption, price shocks and limited domestic refining capacity. The resulting volatility is not only a consumer-pricing issue; it is a structural national-resilience issue.
A Pacific-facing Luzon refinery allows Western Canadian Select crude to arrive from Canada across the open Pacific, reducing exposure to the Strait of Hormuz, Bab el-Mandeb, Suez Canal, Malacca Strait and South China Sea routing risks that define much of Asia's conventional oil-supply exposure.
The platform can contribute to domestic refining depth, advanced-fuels exports, import substitution, skilled employment, hard-currency revenue and long-term fuel-security resilience. The host-country alignment is central to incentives access, permitting support and ECA financing relevance.
| Host-country engagement element | DM-XTech approach | Strategic value |
|---|---|---|
| National fuel-security case | Commission an economic-impact study and fuel-security analysis to document the refinery's contribution to Philippine import substitution and energy resilience. | Creates a government-facing narrative that supports permitting, incentives and bilateral investment-treaty frameworks. |
| Canada–Philippines WCS corridor brief | Document the Pacific crude route, Canada–Philippines trade dimensions and WCS supply-chain economics. | Engages Canadian trade and export-credit apparatus; supports ECA financing strategy. |
| Philippine government engagement | Direct engagement with relevant Philippine government agencies on fuel-security, BOI incentives, PEZA eligibility and host-country agreement pathway. | Political risk mitigation; access to fiscal incentives; sovereign support for project financing. |
| DM-XTechPhil footprint | DM-XTechPhil's existing Philippine incorporation and technical relationships support credibility of the host-country narrative. | Demonstrates pre-existing commercial commitment to the Philippines beyond the refinery proposal. |
The Series A is designed to make DM-XTech UK a credible deSPAC target for large-cap SPAC sponsors seeking scalable energy-transition infrastructure, aviation decarbonisation and strategic fuel security. The deSPAC is not presented as guaranteed; it is presented as the capital-markets pathway that can anchor the much larger refinery financing.
| SPAC target profile | Indicative characteristics |
|---|---|
| Sector focus | Energy transition, clean-energy infrastructure, aviation decarbonisation, fuel security or Pacific-facing industrial platforms. |
| Indicative SPAC trust size | US$300M–US$600M as a working target range, commensurate with refinery-platform ambition and PIPE co-investment expectations. Larger sponsors considered where strategic PIPE anchor is available. |
| Preferred jurisdiction | NYSE or NASDAQ. UK or Singapore listings considered as alternatives or complements depending on sponsor and investor base. |
| Sponsor engagement status | No formal SPAC sponsor mandate has been entered into. The Series A evidence package (CPOAs, TMA, pre-FEED, governance) is designed to create the conditions for credible sponsor engagement. Sponsor outreach is anticipated as a Phase 7 activity (see Section 16: Milestones). |
| PIPE strategy | Target PIPE anchor from strategic energy-sector investors, sovereign wealth funds or aviation-sector participants whose commercial interest aligns with DM-XTech's product and platform strategy. |
| ECA relevance | The Canada–Philippines WCS corridor creates potential relevance for Export Development Canada (EDC) and Philippine government-backed financing institutions alongside multilateral DFIs. |
Series A Preferred Equity → institutional management → CPOA conversion → TMA execution → WCS platform diligence → Philippine host-country alignment → SPAC sponsor engagement → PIPE / strategic anchor → potential deSPAC → syndicated project financing.
The DM-XTech group currently operates through two principal entities. DM-XTech UK Ltd. is the UK-incorporated commercial and capital-markets vehicle. DM-XTechPhil is the Philippine-incorporated technology source entity. Formalising the legal relationship between these two entities is a Series A priority. The structure below reflects the intended post-Series A architecture.
Incorporated in England and Wales. The Series A issuer and holder of the UK/EU commercial mandate.
Incorporated in the Philippines. Under founder control; related entity to DM-XTech UK Ltd.
A dedicated special-purpose vehicle will be established in the Philippines or an appropriate offshore jurisdiction to hold the WCS Refinery project, attract project financing and structure host-country agreements.
The commercial integrity of the entire platform depends on a formally documented, arm's-length IP licensing agreement between DM-XTech UK and DM-XTechPhil. Without it, DM-XTech UK's rights to commercialise the formulations remain informal and cannot withstand SPAC sponsor, PIPE or project-finance due diligence.
The financial scenarios below are illustrative only. They are presented to give investors a working framework for understanding the order of magnitude of revenues, costs and capital requirements at each stage of DM-XTech's commercial development. None of these figures constitute profit forecasts, audited projections or guarantees of any kind. All assumptions are subject to independent financial model diligence.
| Stage | Description | Illustrative revenue range | Key assumptions |
|---|---|---|---|
| TMA / CPOA Stage (Years 1–2) | Revenue from first-adopter CPOA shipments of tLCAF and DoC Jet A-1 produced under the TMA. | US$10M–30M per year (indicative, depending on CPOA uptake, lot volumes and pricing). | 1–3 first-adopter CPOA shipments per year at minimum commercial lot size; TMA economics validated; no refinery capex at this stage. |
| SPAC / deSPAC Stage (Year 2–3) | Public equity raised via deSPAC to capitalise the WCS Refinery pre-development and attract PIPE and project-finance interest. | SPAC trust: US$300M–600M indicative (subject to market conditions). PIPE: additional US$100M–300M from strategic investors. | Series A evidence package complete; SPAC sponsor secured; customer CPOA pipeline demonstrable; pre-FEED commissioned. |
| WCS Refinery Construction (Years 3–7) | Refinery capex programme funded by deSPAC equity, project-finance debt and ECA support. | Capex: US$3–6 billion (indicative range, subject to pre-FEED and site assessment). Not funded by Series A. | Site secured; Philippine host-country agreements in place; FEED complete; EPC contract awarded; WCS crude supply agreements executed. |
| WCS Refinery Steady State (Year 7+) | Full-capacity production of tLCAF, DoC Jet A-1 and advanced fuels for Pacific aviation markets at parity pricing. | Revenue potential: US$500M–1.5B+ per year at scale, depending on capacity, product mix and prevailing aviation-fuel economics. Highly illustrative. | Refinery commissioned and operating efficiently; parity pricing with conventional Jet A-1 achieved; product slate includes SAF island; Pacific aviation demand continues to grow. |
| Series A investor scenario | Illustrative outcome | Key dependencies |
|---|---|---|
| deSPAC exit (base case) | Series A preferred shares convert into public-company stock at deSPAC closing. Illustrative conversion value at 3–5× Series A entry, depending on SPAC pricing and PIPE terms negotiated. | Successful SPAC sponsor engagement; PIPE anchor secured; CPOA and TMA milestones achieved; market conditions supportive. |
| Strategic acquisition (alternative) | DM-XTech UK is acquired by a major energy company or aviation fuel group prior to or instead of deSPAC. Series A preferred shareholders receive liquidation preference plus participation. | Acquirer interest in UK/EU CPOA position, Philippine WCS platform and proprietary fuel formulations. |
| Extended private hold (downside) | deSPAC delayed; Series A preferred shareholders retain cumulative dividend accrual and liquidation preference ahead of ordinary equity. No assurance of exit timeline. | SPAC market conditions deteriorate; CPOA or TMA milestones delayed; reduced investor appetite. |
Each Series A milestone produces an evidence package that can be examined by investors, SPAC sponsors, airlines, verifiers, banks, ECAs and host-country stakeholders. Indicative timeframes below are management's working plan from Series A close; they are subject to revision based on market conditions and execution progress.
Appoint Chairman / Chair-designate, CFO / CFO-designate, operations leader, General Counsel and core adviser bench. Execute IP licensing agreement between DM-XTech UK and DM-XTechPhil. Establish technical claims review committee and TERC engagement scope. Begin audit readiness programme.
Launch first-adopter airline and defence aviation CPOA programme for tLCAF and DoC Jet A-1 in UK/EU markets. Issue first MRV-relevant fuel-property documentation and data packs. Target minimum two signed CPOAs (including at least one airline and one defence aviation user) within six months of close.
Select and qualify refinery counterparty; finalise TMA; complete formulation-transfer protocol under trade-secret controls; prepare first batch production plan. Target TMA signed and first production batch scheduled within eight months of close.
Produce batch-specific fuel-property documentation, traceability materials and verifier-facing data packs from first TMA production batch. Execute first CPOA shipment to a first-adopter customer. Provide investors with a complete first-shipment evidence package.
Prepare the national fuel-security case, economic-impact study, incentives and permits map, Pacific-facing site strategy and Canada–Philippines WCS corridor brief. Initiate formal engagement with relevant Philippine government agencies. Target a documented host-country engagement package by Month 15.
Complete pre-FEED scope, Pacific-facing site assessment, WCS supply chain analysis, refinery configuration study, product slate definition, SAF/eSAF route and preliminary bankability model. Target a pre-FEED-ready package by Month 18 capable of supporting project-finance and SPAC sponsor review.
Prepare sponsor deck, PIPE deck, data room, risk register, controls plan, public-company financial model and transaction documentation. Begin formal SPAC sponsor engagement. Target at least one SPAC sponsor in active dialogue by Month 24, with a deSPAC transaction anticipated in the 24–36 month window from Series A close, subject to market conditions.
The opportunity is significant, but it depends on product, commercial, manufacturing, regulatory, governance and mega-project execution. Institutional-grade disclosure improves credibility with the intended investor base.
The commercial platform depends on a formal, legally documented IP licensing agreement between DM-XTech UK and DM-XTechPhil. Until that agreement is executed, DM-XTech UK's rights to the proprietary formulations are informal and cannot withstand SPAC or project-finance diligence. This is the highest-priority legal risk and is explicitly funded by the Series A.
Fuel-property documentation may be relevant to airline MRV workflows, but it does not guarantee acceptance by verifiers, competent authorities, NEATS or any specific regulatory regime.
First-adopter airlines, air forces and fuel distributors may not enter into CPOAs or may delay procurement pending internal, technical, legal or operational review.
TMA production depends on refinery selection, commercial terms, capacity, confidentiality, process compatibility, product isolation, QA release and export/import logistics.
Each batch must meet ASTM D1655 and product-specific DM-XTech specifications. Claims regarding contrails, nvPM, occupational exposure, CORSIA or EU MRV must remain evidence-based and bounded.
The company requires public-company-grade management, independent governance, finance controls and legal architecture to support a Series A and deSPAC pathway. The transition from founder-led to institutionally governed company carries execution and cultural risk.
No deSPAC is assured. Valuation, redemptions, PIPE appetite, SEC disclosure standards, sponsor economics and market timing may prevent or delay a transaction.
The refinery requires site control, permits, FEED, EPC, environmental and social studies, WCS crude supply agreements, product offtake, host-country support and multi-billion-dollar project financing.
Conventional Jet A-1 parity depends on refinery scale, feedstock economics, financing cost, yield, logistics, hydrogen, power and carbon costs — none of which are guaranteed at the values assumed in any financial model.
Host-country political risk, regulatory change, permitting delay, South China Sea geopolitical dynamics and Canada–Philippines trade conditions could affect the refinery platform's bankability and timeline.
Common founder control of both entities creates related-party conflict-of-interest risks that must be managed through independent board oversight, arm's-length transaction governance and transparent disclosure.
Series A preferred shares are illiquid until a deSPAC, strategic sale or other liquidity event. There is no guarantee of exit timeline or valuation. Investors must be prepared to hold for an extended period.
Confidential — not for distribution. Subject to all notices and disclaimers stated herein.